<DOC>
	<DOCNO>NCT01688193</DOCNO>
	<brief_summary>The purpose study Evaluate Compare Safety Pharmacokinetics HCP1004 VIMOVO 500/20mg Healthy Korean Male</brief_summary>
	<brief_title>Study Evaluate Compare Safety Pharmacokinetics HCP1004 VIMOVO 500/20mg Healthy Korean Male</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>BMI : 18.0 27.0 kg/m2 Willingness sign write Informed Consent Form Evidence clinically relevant pathology History relevant drug food allergy Positive screen drug abuse Participation drug study within 60 day prior drug administration .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>